Le programme de ces symposiums est défini par un Comité Scientifique.
|
2010
|
The role of blood antigens and associated molecules in red cell biology: from molecular
approaches to clinical applications
|
|
2009
|
Molecular Biology of red cells : from research to diagnosis (with SFTS)
|
|
2008
|
Adhesion molecules in red cell-endothelium interaction: impact on sickle cell and
malaria
|
|
2007
|
Clinical use of blood products
|
|
2006
|
Blood transfusion in Europe- Transfusion safety with regard to parasites, prions
- Prevention and ethical aspects
|
|
2005
|
Consensus and discordances in transfusion medicine - Ethics of blood donation and
self-sufficiency - Accidents by ABO incompatibility
|
|
2004
|
Advances in transfusion-immunosuppressed recipients of blood products - Transfusion
safety with regards to blood-borne agents
|
|
2003
|
Hepatitis B - Universal RBC New donors - New recipients of blood
|
|
2002
|
Prions - Residual risks
|
|
2000
|
HIV and HCV from screening to immunotherapy
|
|
1999
|
Gene invalidation and RBC diseases :from genetics to transfusion therapy
|
|
1998
|
Prions diseases - Malaria
|
|
1997
|
Impact of molecular biology techniques on transfusion medicine - Cell therapy
|
|
1996
|
Gene therapy - Hepatitis C
|
|
1995
|
Hemoglobin carriers: from risk to prevention in transfusion medicine
|
|
1994
|
Platelets and blood transfusion - Immunoglobulins in transfusion practice
|
|
1993
|
Molecular biology of blood groups – Immunohematology and risks in transfusion medicine
- Nitrogen oxyde (NO): its role in transfusion medicine - Hemoglobinopathies
|
|
1992
|
Blood substitutes - Viral inactivation of blood products
|